| Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174 … N Nagot, C Kankasa, JK Tumwine, N Meda, GJ Hofmeyr, R Vallo, ... The Lancet 387 (10018), 566-573, 2016 | 95 | 2016 |
| Polypharmacy definitions for multimorbid older adults need stronger foundations to guide research, clinical practice and public health C Sirois, NS Domingues, ML Laroche, A Zongo, C Lunghi, L Guénette, ... Pharmacy 7 (3), 126, 2019 | 68 | 2019 |
| The impact of incident depression on medication adherence in patients with type 2 diabetes C Lunghi, A Zongo, J Moisan, JP Gregoire, L Guénette Diabetes & metabolism 43 (6), 521-528, 2017 | 48 | 2017 |
| Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression C Lunghi, A Zongo, J Moisan, JP Grégoire, L Guénette Journal of Diabetes and its Complications 31 (7), 1200-1206, 2017 | 27 | 2017 |
| A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada A Asselin, OB Lamarre, R Chamberland, SJ McNeil, E Demers, A Zongo Journal of Cannabis Research 4 (1), 26, 2022 | 19 | 2022 |
| Predictive validity of self-reported measures of adherence to noninsulin antidiabetes medication against control of glycated hemoglobin levels A Zongo, L Guénette, J Moisan, JP Grégoire Canadian journal of diabetes 40 (1), 58-65, 2016 | 19 | 2016 |
| Revisiting the internal consistency and factorial validity of the 8-item Morisky Medication Adherence Scale A Zongo, L Guénette, J Moisan, L Guillaumie, S Lauzier, JP Grégoire SAGE Open Medicine 4, 2050312116674850, 2016 | 16 | 2016 |
| Change in trajectories of adherence to lipid‐lowering drugs following non‐fatal acute coronary syndrome or stroke A Zongo, S Simpson, JA Johnson, DT Eurich Journal of the American Heart Association 8 (23), e013857, 2019 | 12 | 2019 |
| Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study A Zongo, S Simpson, JA Johnson, DT Eurich Plos one 14 (9), e0223062, 2019 | 12 | 2019 |
| Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study W Alkabbani, A Zongo, JK Minhas-Sandhu, DT Eurich, BR Shah, ... Canadian Journal of Diabetes 46 (4), 392-403. e13, 2022 | 11 | 2022 |
| Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: a nested case-control study C Lunghi, A Zongo, I Tardif, É Demers, JDR Diendéré, L Guénette Diabetes Research and Clinical Practice 171, 108566, 2021 | 11 | 2021 |
| Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study A Zongo, C Lee, JRB Dyck, J El-Mourad, E Hyshka, JG Hanlon, DT Eurich BMC Cardiovascular Disorders 21, 1-9, 2021 | 10 | 2021 |
| Prevalence of traditional medicines use and adverse events: a population-based cross-sectional survey in Burkina Faso K Ouoba, H Lehmann, A Zongo, JY Pabst, R Semdé European Journal of Integrative Medicine 51, 102129, 2022 | 9 | 2022 |
| Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study W Alkabbani, A Zongo, JK Minhas-Sandhu, DT Eurich, BR Shah, ... BMJ Open Diabetes Research and Care 9 (2), e002496, 2021 | 9 | 2021 |
| Insights into the interplay between KIR gene frequencies and chronic HBV infection in Burkina Faso PA Sorgho, JJ Martinson, FW Djigma, AT Yonli, BM Nagalo, ... Mediterranean Journal of Hematology and Infectious Diseases 10 (1), 2018 | 9 | 2018 |
| Incidence and predictors of cannabis-related poisoning and mental and behavioral disorders among patients with medical cannabis authorization: a cohort study A Zongo, C Lee, JRB Dyck, J El-Mourad, E Hyshka, JG Hanlon, DT Eurich Substance Use & Misuse 57 (10), 1633-1641, 2022 | 7 | 2022 |
| Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus W Alkabbani, A Zongo, JK Minhas‐Sandhu, DT Eurich, BR Shah, ... Diabetic Medicine 39 (8), e14858, 2022 | 6 | 2022 |
| Measuring adherence to oral antidiabetic multi-drug treatment: comparative validity of prescription claims-based adherence measures against hospitalization A Zongo, JP Grégoire, J Moisan, L Guénette Research in Social and Administrative Pharmacy 15 (6), 738-743, 2019 | 6 | 2019 |
| Polypharmacy definitions for multimorbid older adults need stronger foundations to guide research, clinical practice and public health. Pharmacy. 2019; 7 (3): 126 C Sirois, NS Domingues, ML Laroche, A Zongo, C Lunghi, L Guénette | 6 | |
| Are lipid-lowering and antihypertensive medications used as complements to heart-healthy diets? A scoping review. C Desjardins, M Cyrenne-Dussault, O Barbier, A Bélanger, A Gangloff, ... Advances in Nutrition, 2023 | 5 | 2023 |
